Home > Balance Sheet > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹235 Cr₹101 Cr₹-142 Cr₹-300 Cr₹-422 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS is ₹235 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹235 Cr
Mar2024₹101 Cr
Mar2023₹-142 Cr
Mar2022₹-300 Cr
Mar2021₹-422 Cr

How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹235 Cr
132.43
Mar2024 ₹101 Cr
Positive
Mar2023 ₹-142 Cr
Negative
Mar2022 ₹-300 Cr
Negative
Mar2021 ₹-422 Cr -

Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹133,314.4 Cr -3.7% 4% 18.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,037.0 Cr -3% -3.6% -4.9% Stock Analytics
DIVIS LABORATORIES ₹170,795.0 Cr -3.1% 0.1% 11.4% Stock Analytics
CIPLA ₹116,933.0 Cr -1.3% -4.6% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,350.2 Cr -4.2% -7% -11.4% Stock Analytics
MANKIND PHARMA ₹91,355.8 Cr -4.3% 1.5% -21.3% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-3.7%

4%

18.8%

SENSEX

-1.7%

-1.4%

7%


You may also like the below Video Courses